Scientific Reports (Jun 2021)

Inter-vendor performance of deep learning in segmenting acute ischemic lesions on diffusion-weighted imaging: a multicenter study

  • Deniz Alis,
  • Mert Yergin,
  • Ceren Alis,
  • Cagdas Topel,
  • Ozan Asmakutlu,
  • Omer Bagcilar,
  • Yeseren Deniz Senli,
  • Ahmet Ustundag,
  • Vefa Salt,
  • Sebahat Nacar Dogan,
  • Murat Velioglu,
  • Hakan Hatem Selcuk,
  • Batuhan Kara,
  • Ilkay Oksuz,
  • Osman Kizilkilic,
  • Ercan Karaarslan

DOI
https://doi.org/10.1038/s41598-021-91467-x
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 10

Abstract

Read online

Abstract There is little evidence on the applicability of deep learning (DL) in the segmentation of acute ischemic lesions on diffusion-weighted imaging (DWI) between magnetic resonance imaging (MRI) scanners of different manufacturers. We retrospectively included DWI data of patients with acute ischemic lesions from six centers. Dataset A (n = 2986) and B (n = 3951) included data from Siemens and GE MRI scanners, respectively. The datasets were split into the training (80%), validation (10%), and internal test (10%) sets, and six neuroradiologists created ground-truth masks. Models A and B were the proposed neural networks trained on datasets A and B. The models subsequently fine-tuned across the datasets using their validation data. Another radiologist performed the segmentation on the test sets for comparisons. The median Dice scores of models A and B were 0.858 and 0.857 for the internal tests, which were non-inferior to the radiologist’s performance, but demonstrated lower performance than the radiologist on the external tests. Fine-tuned models A and B achieved median Dice scores of 0.832 and 0.846, which were non-inferior to the radiologist's performance on the external tests. The present work shows that the inter-vendor operability of deep learning for the segmentation of ischemic lesions on DWI might be enhanced via transfer learning; thereby, their clinical applicability and generalizability could be improved.